Related Experiment Video
Updated: Jul 5, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
[Interstitial pneumonitis in a patient treated with amiodarone -- case report]
Anna Paczek1, Monika Szturmowicz, Elzbieta Wiatr
1Klinika Chorob Wewnetrznych Klatki Piersiowej Instytutu Gruzlicy i Chorob Pluc w Warszawie, Poland. 4klinika@igichp.edu.pl
Abstract:
Amiodarone, antiarrhythmic drug of III class is used in patients with supraventricular and ventricular arrhythmias, often with coexisting congestive heart failure. Side effects of amiodarone treatment are observed in approximately 75% of patients. Most dangerous are the symptoms of amiodarone pulmonary toxicity occuring in 2-17% of patients. We present a patient with COPD, in whom interstitial pneumonitis with radiologic features of organizing pneumonia developed after one year of amiodaron treatment due to supraventricular and ventricular arrhythmias. The drug was stopped and steroids were introduced due to marked respiratory insufficiency. Regression of pulmonary symptoms and improvement of ventilatory parameters were observed after 3 months of treatment. Pathogenesis, diagnostic procedures and current methods of treatment of this jatrogenic disease are discussed.
Related Concept Videos
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Myocarditis III: Medical Management
Chronic Obstructive Pulmonary Disease I: Introduction
Chronic Obstructive Pulmonary Disease-I: Introduction

